Autoimmunity linked protein phosphatase PTPN22 as a target for cancer immunotherapy

Rafael Cubas(Theravance Biopharma (United States)), Andrew C. Chan(Howard Hughes Medical Institute)
Journal for ImmunoTherapy of Cancer
October 1, 2020
Cited by 50


Related Papers